Clinical trial · Observational
Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging
NCT03214341CI-TRIAL-00028567unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Differentiation between benign and malignant mediastinal tumors as well as characterization and grading of malignancy which is essential for treatment planning as well as for prognosis
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mediastinal Tumor | Mediastinal Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRI diffusion | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- sensitivity and specificity of magnetic resonance imaging diffusion in mediastinal masses
- timeFrame
- up to one month
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Any age groups * diagnosis of mediastinal mass (by Multislice Computed Tomography). Exclusion Criteria: * chemotherapy radiotherapy. * thoracic surgery. * cystic mass . * mass with large amount of necrosis or calcification. * contraindication of MRI (e.g. pacemakers , claustrophobia).
References
Publications (0)
Data not yet available
No reference posted for this study.